首页 > 最新文献

Im Fokus Onkologie最新文献

英文 中文
Diente Krebs als „Alibi“ für einen Mord? 癌症是谋杀的 "不在场证明 "吗？
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3755-z
Lamia Özgör
{"title":"Diente Krebs als „Alibi“ für einen Mord?","authors":"Lamia Özgör","doi":"10.1007/s15015-024-3755-z","DOIUrl":"https://doi.org/10.1007/s15015-024-3755-z","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"153 1","pages":"64"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140781540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immuntherapie: Keine Angst vor den Nebenwirkungen 免疫疗法：不要害怕副作用
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3805-6
Mascha Pömmerl
{"title":"Immuntherapie: Keine Angst vor den Nebenwirkungen","authors":"Mascha Pömmerl","doi":"10.1007/s15015-024-3805-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3805-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"528 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wie sieht die Onkologie in der Zukunft aus? 未来的肿瘤学会是什么样子？
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3809-2
Redaktion Facharztmagazine
{"title":"Wie sieht die Onkologie in der Zukunft aus?","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15015-024-3809-2","DOIUrl":"https://doi.org/10.1007/s15015-024-3809-2","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"76 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140755493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TNBC: Toripalimab plus nab-Paclitaxel verzögert die Progression TNBC：托利帕单抗联合纳布-紫杉醇抑制病情恶化
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3790-9
Robert Bublak
{"title":"TNBC: Toripalimab plus nab-Paclitaxel verzögert die Progression","authors":"Robert Bublak","doi":"10.1007/s15015-024-3790-9","DOIUrl":"https://doi.org/10.1007/s15015-024-3790-9","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"76 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Das ist neu in der Leitlinie Ösophaguskarzinom 食道癌指南的新内容
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3761-1
E. Oberhofer
{"title":"Das ist neu in der Leitlinie Ösophaguskarzinom","authors":"E. Oberhofer","doi":"10.1007/s15015-024-3761-1","DOIUrl":"https://doi.org/10.1007/s15015-024-3761-1","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"203 ","pages":"39-43"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140792336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RCC: Länger progressionsfrei mit Cabozantinib RCC：使用卡博替尼可获得更长的无进展时间
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3807-4
Redaktion Facharztmagazine
{"title":"RCC: Länger progressionsfrei mit Cabozantinib","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15015-024-3807-4","DOIUrl":"https://doi.org/10.1007/s15015-024-3807-4","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"27 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140797522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weniger Dysphagie dank optimierter Strahlentherapie 优化放射治疗，减少吞咽困难
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3779-4
Marie-Thérèse Weitzl
{"title":"Weniger Dysphagie dank optimierter Strahlentherapie","authors":"Marie-Thérèse Weitzl","doi":"10.1007/s15015-024-3779-4","DOIUrl":"https://doi.org/10.1007/s15015-024-3779-4","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"303 2","pages":"45"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140775848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumortherapiefelder verlängern Überlebenszeit bei NSCLC 肿瘤治疗场可延长非小细胞肺癌患者的生存时间
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3777-6
T. Müller
{"title":"Tumortherapiefelder verlängern Überlebenszeit bei NSCLC","authors":"T. Müller","doi":"10.1007/s15015-024-3777-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3777-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"31 4","pages":"34"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140785474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HR-positiver BC: Adjuvant therapieren gemäß dem individuellen Risiko HR 阳性 BC：根据个体风险进行辅助治疗
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3804-7
Mascha Pömmerl
{"title":"HR-positiver BC: Adjuvant therapieren gemäß dem individuellen Risiko","authors":"Mascha Pömmerl","doi":"10.1007/s15015-024-3804-7","DOIUrl":"https://doi.org/10.1007/s15015-024-3804-7","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"57 33","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140795551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eltrombopag bei Niedrig-Risiko-MDS mit Thrombozytopenie wirksam 艾曲波帕对伴有血小板减少的低风险 MDS 有效
Im Fokus Onkologie
Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3769-6
F. Klein
{"title":"Eltrombopag bei Niedrig-Risiko-MDS mit Thrombozytopenie wirksam","authors":"F. Klein","doi":"10.1007/s15015-024-3769-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3769-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"58 43","pages":"61"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140795422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Im Fokus Onkologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1